QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the fourth quarter of 2025.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Explore the vital role of academic reform in strengthening paramedics and allied health professionals for a resilient ...

External beam radiotherapy (EBRT) is a cornerstone of cancer treatment, with ongoing advances in imaging, motion management, ...

The ReproSci project retrospectively analyzed the reproducibility of 1006 claims from 400 papers published between 1959 and 2011 in the field of Drosophila immunity. This project attempts to provide a ...